AOD-9604
A modified fragment of human growth hormone discussed in weight-management and fat-metabolism circles, but not approved as an FDA drug.
Also referenced as: Advanced Obesity Drug-9604
This name primarily lives in the research market and should not be read like an approved pharmaceutical product.
This profile is grouped by its dominant research and market lane, not by vendor shelf placement.
Advanced Obesity Drug-9604
No FDA label signal · 0 trials · 11 PubMed results
What AOD-9604 is
AOD-9604 is a modified fragment of human growth hormone built around amino acids 176-191. It is usually discussed as a body-composition or weight-management compound rather than as a classic growth-hormone replacement medicine.
Why people track it
The compound shows up often in peptide conversations because it is framed as a metabolic or lipolytic fragment rather than a full GH analog. That distinction is part of the marketing story around it, but it is not the same thing as having an FDA-approved obesity indication.
Regulatory context
AOD-9604 is not an FDA-approved drug in the United States. On this site it belongs in the research-market bucket, not the approved-medicine bucket.
Practical reading note
If you see aggressive claims around AOD-9604, the useful questions are:
- what jurisdiction is being referenced
- whether the seller is describing a research product or a regulated medicine
- and whether any claimed outcome is coming from robust human evidence or from broader peptide-marketing language